Expression of IL-18 and its receptor in human leukemia cells

Leukemia Research

Volumn 27, Issue 9, 2003, Pages 813-822

  Zhang, Bin ^a   Ma, Xiao Tong ^a   Zheng, Guo Guang ^a   Li, Ge ^a   Rao, Qing ^a   Wu, Ke Fu ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Autocrine; IL 18; IL 18 receptor; Leukemia; Modulation

Indexed keywords

ALPHA INTERFERON; ANTISENSE OLIGODEOXYNUCLEOTIDE; COLONY STIMULATING FACTOR 1; CYTOKINE ANTIBODY; GAMMA INTERFERON; HUMAN MONOCLONAL ANTIBODY; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; LIGAND; MESSENGER RNA; PROTEIN SUBUNIT; RECOMBINANT INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; MODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION;

EID: 0037600776     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(03)00005-5     Document Type: Article

References (34)

1. Lowenberg B., Touw I.P. Hematopoietic growth factor and their receptors in acute leukemia. Blood. 81:1993;281-292.
2. Russell N.H. Autocrine growth factors and leukemic haemopoiesis. Blood Rev. 6:1992;149-156.
3. Okamura H., Tsutsui H., Kashiwamura S., Yoshimoto T., Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 10:1998;259-264.
4. Mclnnes I.B., Gracie J.A., Leung B.P., Wei X.Q., Liew F.Y. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol. Today. 21:2000;312-315.
5. Taniguchi M., Nagaoka K., Kunikata T., Kayano T., Ymauchi H., Nakamura S.et al. Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA. J. Immunol. Methods. 206:1997;107-113.
6. Wang Y., Li G., Zheng G.G., Song Y.H., Wu K.F. Detection and sequencing analysis of IL-18 expression in J6-1 leukemic cells. Leukemia Res. 25:2001;273-274.
7. Torigoe K., Ushio S., Okura T., Kobayashi S., Taniai M., Kunikate T.et al. Purification and characterization of human interleukin-18 receptor. J. Biol. Chem. 272:1997;25737-25742.
8. Parnet P., Garka K.E., Bonnert T.P., Dower S.K., Sims J.E. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/T2 and IL-1R AcP. J. Biol. Chem. 271:1996;3967-3970.
9. Born T., Thomassen L.E., Bird T.A., Sims J.E. Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J. Biol. Chem. 273:1998;29445-29450.
10. Hoshino K., Tsutsui H., Kawai T., Takeda K., Nakanishi K., Takeda Y.et al. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. J. Immunol. 162:1999;5041-5044.
11. Robinson D., Shibuya K., Mui A., Zonin F., Murphy E., Sana T.et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFκB. Immunity. 7:1997;571-581.
12. Kunikata T., Torigoe K., Ushio S., Okura T., Ushio C., Yamauchi H.et al. Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody. Cell Immunol. 189:1998;135-143.
13. Nakamura S., Otani T., Okura R., Ljiri Y., Motoda R., Kurimoto M.et al. Expression and responsiveness of human interleukin-18 receptor (IL-18R) on hematopoietic cell lines. Leukemia. 14:2000;1052-1059.
14. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R.et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann. Int. Med. 103:1985;620-625.
15. Wu K.F., Luka J., Joshi S., Pirruccello S.J., Masih A., Sharp J.G. Characterization of a human herpes virus-6 (HHV-6) and Epstein-Barr virus (EBV) associated leukemic cell line, J6-1. Chin. J. Cancer Res. 6:1994;157-168.
16. Wu K.F., Rao Q., Zheng G.G., Geng Y.Q., Li M., Kong J.et al. Enhancement of J6-1 human leukemic cell proliferation by cell-cell contact: role of an M-CSF-like membrane-associated growth factor. Leukemia Res. 18:1994;843-849.
17. Wu K.F., Rao Q., Zheng G.G., He Z.H., Ying H.G., Song Y.H.et al. Enhancement of J6-1 human leukemic cell proliferation by MAF-J6-1 through a cell-cell contact mechanism. II. Role of an M-CSF receptor-like membrane protein. Leukemia Res. 22:1998;55-60.
18. Monteleone G., Trapasso F., Parrello T., Biancone L., Stella A., Iuliano R.et al. Bioactive IL-18 expression is up-regulated in Crohn's disease. J. Immunol. 163:1999;143-151.
19. Zhang B., Wang Y., Zheng G.G., Xiao-Tong M., Ge L., Ke-Fu W. Clinical significance of IL-18 over-expression in AML. Leukemia Res. 26:2002;887-892.
20. Zheng G.G., Wu K.F., Geng Y.Q., Kong J., Ayad A.-K., Maria D.et al. Expression of membrane-bound M-CSF in Hodgkin's disease and other hematologic malignancies. Leukemia Lymphoma. 32:1999;339-344.
21. Chu R.S., Askew D., Noss E.H. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing. J. Immunol. 163:1999;1188-1194.
22. Chiaramonte M.G., Hesse M., Cheever A.W., Wynn T.A. CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism. J. Immunol. 164:2000;973-985.
23. Okamura H., Tsutsui H., Kashiwamura S., Yoshimoto T., Nakanishi K. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70:1998;281-312.
24. Ahn H.J., Maruo S., Tomura M., Mu J., Hamaoka T., Nakanishi K.et al. A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma. J. Immunol. 159:1997;2125-2131.
25. Wu K.F., Zhu Y.M., Rao Q., Chu J.X., Zhao J.M. Expression of transforming growth factor-beta. Ann. New York Acad. Sci. 628:1991;151.
26. Carter A., Draxler I.S., Tatarsky I. Effect of interleukin-1, tumor necrosis factor-α, and interferon-α on the blast cells of acute myeloblastic leukemia. Am. J. Hematol. 40:1992;245-251.
27. Dunbar C.E., Browder T.M., Abram J.S., Nienhuis A.W. COOH-terminal-modified IL-3 is retained intracellularly and stimulates autocrine growth. Science. 245:1989;1493-1496.
28. Bejcek B.E., Li D.Y., Deuel T.F. Transformation by v-sis occurs by an internal autoactivation mechanism. Science. 245:1989;1496-1499.
29. Tang S.S., Zheng G.G., Wu K.F., Chen G.B., Liu H.Z., Rao Q. Autocrine and possible intracrine regulation of HL-60 cell proliferation by M-CSF. Leukemia Res. 25:2001;1107-1114.
30. Krueger G.R., Kudlimay D., Ramon A., Klueppelberg U., Schumacher K. Demonstration of active and latent Epstein-Barr virus and human herpevirus-6 infections in bone marrow cells of patients with myelodysplasia and chronic myeloproliferative diseases. In Vivo. 8:1994;533-542.
31. Krueger G.R., Huetter M.L., Rojo J., Romero M., Cruz-Ortiz H. Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkin's and Kikuchi's diseases and their relation to proliferation and apoptosis. Anticancer Res. 21:2001;2155-2161.
32. Mizuno S., Akashi K., Ohshima K., Iwasaki H., Miyamoto T., Uchida N.et al. Interferon-gamma prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukemia in an autocrine fashion. Blood. 93:1999;3494-3504.
33. Konishi K., Tanabe F., Taniguchi M., Yamauchi H., Tanimoto T., Ikeda M.et al. A simple and sensitive bioassay for the detection of human interleukin-18/interferon-gamma-inducing factor using human myelomonocytic KG-1 cells. J. Immunol. Methods. 209:1997;187-191.
34. Sareneva T., Julkunen I., Matikainen S. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 165:2000;1933-1938.